AI | pharmaphorum

AI

Digital

navigating intellectual property challenges

Risk management strategies to navigate IP challenges associa...

Artificial intelligence (AI) is revolutionising industries. But with this exciting new frontier comes a complex challenge: protecting your intellectual property (IP).

Digital

AI in Medical Communications: Revolutionising the present, r...

Artificial intelligence (AI) is poised to transform Medical Communications.

Digital

Ada Health Team interview with Jonah Comstock

Reuters Pharma USA 2024 – Nick Altebrando and Shireen Saxena

When it comes to patient-facing AI in healthcare, ChatGPT, with its tendency toward hallucination, is not going to cut it.

R&D

Harnessing the velocity of biopharmaceutical advances

Today’s pharmaphorum podcast addresses the subject of speed – the velocity at which biopharma is bringing new therapies and medicines to market faster.

R&D

AI-powered real-world evidence generation for biotechs

The biopharma industry faces a relentless demand for evidence of real-world effectiveness (RWE), safety, and value throughout the product lifecycle to complement the clinical trial-based be

R&D